SQI Diagnostics, Inc. engages in developing and selling testing kits, services, and automated testing systems to clinical laboratories, hospitals, clinicians, and diagnostic testing companies. It operates through the following segments: Development of Organ Health Diagnostic Tests; COVID-19-Related Diagnostics Tests; Direct-to-Consumer Tests for Celiac and Rheumatoid Arthritis Diseases; and Distribution of Existing COVID-19 Polymerase Chain Reaction and Antigen Tests. The company was founded by Peter Lea in 1999 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of SQI Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. SQI Diagnostics Inc market cap is $6.11M.
What is the 52-week high for SQI Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. SQI Diagnostics Inc 52 week high is $0.0149 as of October 10, 2025.
What is the 52-week low for SQI Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SQI Diagnostics Inc 52 week low is $0.0149 as of October 10, 2025.
What was SQI Diagnostics Inc stock price yesterday?
SQI Diagnostics Inc stock price yesterday was $0.0149.
What is the 50-day moving average of SQI Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. SQI Diagnostics Inc 50-day moving average is $0.0149.